NDC 71610-316 – Pregabalin

Pregabalin 100 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CV

Product NDC71610-316

Product details

Brand name
Pregabalin
Generic name
Pregabalin
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA211384
Marketed since
July 19, 2019
Listing expires
December 31, 2026

Active ingredients

Uses, dosage, side effects and warnings for Pregabalin →

Package NDC codes (9)

Package NDCDescriptionSince
71610-316-3030 CAPSULE in 1 BOTTLE (71610-316-30)Aug 12, 2019
71610-316-4656 CAPSULE in 1 BOTTLE (71610-316-46)Aug 12, 2019
71610-316-5360 CAPSULE in 1 BOTTLE (71610-316-53)Aug 12, 2019
71610-316-5484 CAPSULE in 1 BOTTLE (71610-316-54)Jul 9, 2025
71610-316-6090 CAPSULE in 1 BOTTLE (71610-316-60)Oct 7, 2025
71610-316-70120 CAPSULE in 1 BOTTLE (71610-316-70)Aug 12, 2019
71610-316-75150 CAPSULE in 1 BOTTLE (71610-316-75)Jul 9, 2025
71610-316-80180 CAPSULE in 1 BOTTLE (71610-316-80)Jul 9, 2025
71610-316-92270 CAPSULE in 1 BOTTLE (71610-316-92)Aug 12, 2019

Other Pregabalin products